Nom du produit:8-(dimethylamino)-7-methyl-10-(2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4-dione
IUPAC Name:8-(dimethylamino)-7-methyl-10-(2,3,4,5-tetrahydroxypentyl)-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione
- CAS:51093-55-1
- Formule moléculaire:C18H23N5O6
- Pureté:95%+
- Numéro de catalogue:CM704252
- Poids moléculaire:405.41
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:51093-55-1
- Formule moléculaire:C18H23N5O6
- Point de fusion:-
- Code SMILES:CN(C)C1=C(C)C=C2N=C3C(=O)NC(=O)N=C3N(CC(O)C(O)C(O)CO)C2=C1
- Densité:
- Numéro de catalogue:CM704252
- Poids moléculaire:405.41
- Point d'ébullition:
- N° Mdl:MFCD00211182
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.